An experimental drug (DHED) has been created by researches that is hoped will treat menopause symptoms without any negative side effects. Clinical trials have not yet been approved.
“The rest of the body does not recognize DHED, but the brain does and metabolizes it to estrogen,” said Laszlo Prokai, PhD, Professor and Robert A. Welch Chair in Biochemistry. “Since DHED delivers estrogen only in the brain, it spares other organs from hormone exposure, along with its side effects.”
Current methods of treatment include hormone replacement therapy however in 2002 a clinical study called the Women’s Health Initiative was undertaken investigating the long term benefits of the therapy. There were concerns that such treatments could lead to life threatening risks such as cancer. Many women today still opt for the treatment however under professional guidance receive smaller doses.